Nano-X Imaging (NNOX) Cash from Financing Activities (2021 - 2025)
Nano-X Imaging (NNOX) reported Cash from Financing Activities of $15.5 million for Q4 2025, down 59.01% on a YoY basis from $37.8 million in Q4 2024, and up 170.35% quarter-over-quarter from $5.7 million in Q3 2025.
Nano-X Imaging (NNOX) Cash from Financing Activities (2021 - 2025) Analysis & Trends
Nano-X Imaging has reported Cash from Financing Activities for 5 years, with the latest figure at $15.5 million in Q4 2025.
- For the quarter ending Q4 2025, Cash from Financing Activities fell 59.01% year-over-year to $15.5 million; the trailing twelve-month figure through Dec 2025 stood at $21.4 million (down 45.91% YoY), and the FY2025 full-year result was $21.4 million, down 45.91% from the prior year.
- Cash from Financing Activities for Q4 2025 stood at $15.5 million, up from $5.7 million in the prior quarter.
- The five-year high for Cash from Financing Activities was $37.8 million in Q4 2024, with the low at -$12.0 million in Q2 2021.
- Historically, Cash from Financing Activities has averaged $5.1 million across 5 years, with a median of $176000.0 in 2023.
- Annual changes were most pronounced in 2023 — Cash from Financing Activities slumped 368.84% — and 2024, when it jumped 114560.61%.
- Nano-X Imaging's Cash from Financing Activities stood at $1.0 million in 2021, then plunged by 83.33% to $174000.0 in 2022, then sank by 81.03% to $33000.0 in 2023, then jumped by 114560.61% to $37.8 million in 2024, then slumped by 59.01% to $15.5 million in 2025.
- The last three Cash from Financing Activities figures came in at $15.5 million (Q4 2025), $5.7 million (Q3 2025), and $121000.0 (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Nano-X Imaging | 3.62 Mn | -55.99 Mn | -3.62 Mn | 15.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 15.51 Mn |
| Dec 31, 2025 | 15.51 Mn |
| Sep 30, 2025 | 5.74 Mn |
| Sep 30, 2025 | 5.74 Mn |
| Mar 31, 2025 | 121,000.00 |
| Mar 31, 2025 | 121,000.00 |
| Dec 31, 2024 | 37.84 Mn |
| Dec 31, 2024 | 37.84 Mn |
| Sep 30, 2024 | 1.62 Mn |
| Sep 30, 2024 | 1.62 Mn |
| Jun 30, 2024 | 21,000.00 |
| Jun 30, 2024 | 21,000.00 |
| Mar 31, 2024 | 24,000.00 |
| Mar 31, 2024 | 24,000.00 |
| Dec 31, 2023 | 33,000.00 |
| Dec 31, 2023 | 33,000.00 |
| Sep 30, 2023 | 27.41 Mn |
| Sep 30, 2023 | 27.41 Mn |
| Jun 30, 2023 | -371,000.00 |
| Jun 30, 2023 | -371,000.00 |